Publication & Citation Trends
Publications
0 total
P0157 Do cytoreductive treatments improve symptomatic adverse local events and urinary patients reported outcome measures in de novo metastatic prostate cancer? Analysis from a phase II randomised study (IP2-ATLANTA)
Cited by 0
Semantic Scholar
A0522 Complete pathological response of the primary tumour and implications for cytoreductive treatment in de novo metastatic prostate cancer: Analysis from the IP2-ATLANTA phase II randomised study
Cited by 0
Semantic Scholar
Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial.
Cited by 16
Semantic Scholar
A0831 – Novel cytoreductive prostate ablative therapies in de novo metastatic prostate cancer: Lessons learnt from a phase II randomised study (IP2-ATLANTA)
Cited by 0
Semantic Scholar
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol
Cited by 12
Semantic Scholar
MP16-07 RUCAPARIB VS DOCETAXEL OR SECOND-GENERATION ANDROGEN RECEPTOR PATHWAY INHIBITOR THERAPY FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS WITH BRCA MUTATIONS WITH OR WITHOUT LIVER METASTASES IN TRITON3
Cited by 0
Semantic Scholar
Comparative Healthcare Research Outcomes of Novel Surgery in prostate cancer (IP4-CHRONOS): A randomised controlled trial assessing feasibility of randomisation for focal therapy in localised prostate cancer
Cited by 0
Semantic Scholar
A0832 – Additional novel cytoreductive treatments to the primary tumour and metastasis for de novo metastatic-hormone sensitive prostate cancer (IP2-ATLANTA): The internal pilot outcomes of a phase II, multicentre, randomised controlled trial
Cited by 0
Semantic Scholar
Research Topics
Heat shock proteins research
(4)
Prostate Cancer Treatment and Research
(3)
Prostate Cancer Diagnosis and Treatment
(2)
Advanced Radiotherapy Techniques
(2)
Immunotherapy and Immune Responses
(2)
Affiliations
Cancer Genetics (United States)
Cardiff University